172 related articles for article (PubMed ID: 29534506)
1. Saccharin Increases Fasting Blood Glucose but Not Liver Insulin Resistance in Comparison to a High Fructose-Fed Rat Model.
Leibowitz A; Bier A; Gilboa M; Peleg E; Barshack I; Grossman E
Nutrients; 2018 Mar; 10(3):. PubMed ID: 29534506
[TBL] [Abstract][Full Text] [Related]
2. Liquid fructose in pregnancy exacerbates fructose-induced dyslipidemia in adult female offspring.
Rodríguez L; Panadero MI; Rodrigo S; Roglans N; Otero P; Álvarez-Millán JJ; Laguna JC; Bocos C
J Nutr Biochem; 2016 Jun; 32():115-22. PubMed ID: 27142744
[TBL] [Abstract][Full Text] [Related]
3. Allopurinol ameliorates high fructose diet induced hepatic steatosis in diabetic rats through modulation of lipid metabolism, inflammation, and ER stress pathway.
Cho IJ; Oh DH; Yoo J; Hwang YC; Ahn KJ; Chung HY; Jeong SW; Moon JY; Lee SH; Lim SJ; Jeong IK
Sci Rep; 2021 May; 11(1):9894. PubMed ID: 33972568
[TBL] [Abstract][Full Text] [Related]
4. Citrulline and Nonessential Amino Acids Prevent Fructose-Induced Nonalcoholic Fatty Liver Disease in Rats.
Jegatheesan P; Beutheu S; Ventura G; Nubret E; Sarfati G; Bergheim I; De Bandt JP
J Nutr; 2015 Oct; 145(10):2273-9. PubMed ID: 26246323
[TBL] [Abstract][Full Text] [Related]
5. The ergogenic supplement β-hydroxy-β-methylbutyrate (HMB) attenuates insulin resistance through suppressing GLUT-2 in rat liver.
Sharawy MH; El-Awady MS; Megahed N; Gameil NM
Can J Physiol Pharmacol; 2016 May; 94(5):488-97. PubMed ID: 26871756
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the effects of sulforaphane and pioglitazone on insulin resistance and associated dyslipidemia, hepatosteatosis, and endothelial dysfunction in fructose-fed rats.
Shawky NM; Shehatou GSG; Suddek GM; Gameil NM
Environ Toxicol Pharmacol; 2019 Feb; 66():43-54. PubMed ID: 30597379
[TBL] [Abstract][Full Text] [Related]
7. Reduced Nogo expression inhibits diet-induced metabolic disorders by regulating ChREBP and insulin activity.
Zhang S; Guo F; Yu M; Yang X; Yao Z; Li Q; Wei Z; Feng K; Zeng P; Zhao D; Li X; Zhu Y; Miao QR; Iwakiri Y; Chen Y; Han J; Duan Y
J Hepatol; 2020 Dec; 73(6):1482-1495. PubMed ID: 32738448
[TBL] [Abstract][Full Text] [Related]
8. Treatment with myo-inositol attenuates binding of the carbohydrate-responsive element-binding protein to the ChREBP-β and FASN genes in rat nonalcoholic fatty liver induced by high-fructose diet.
Shimada M; Ichigo Y; Shirouchi B; Takashima S; Inagaki M; Nakagawa T; Hayakawa T
Nutr Res; 2019 Apr; 64():49-55. PubMed ID: 30802722
[TBL] [Abstract][Full Text] [Related]
9. Long-term fructose consumption prolongs hepatic stearoyl-CoA desaturase 1 activity independent of upstream regulation in rats.
Liu L; Wang S; Yao L; Li JX; Ma P; Jiang LR; Ke DZ; Pan YQ; Wang JW
Biochem Biophys Res Commun; 2016 Oct; 479(4):643-648. PubMed ID: 27697525
[TBL] [Abstract][Full Text] [Related]
10. Docosapentaenoic acid and docosahexaenoic acid are positively associated with insulin sensitivity in rats fed high-fat and high-fructose diets.
Huang JP; Cheng ML; Hung CY; Wang CH; Hsieh PS; Shiao MS; Chen JK; Li DE; Hung LM
J Diabetes; 2017 Oct; 9(10):936-946. PubMed ID: 27860326
[TBL] [Abstract][Full Text] [Related]
11. Differential Effects of Chronic Ingestion of Refined Sugars versus Natural Sweeteners on Insulin Resistance and Hepatic Steatosis in a Rat Model of Diet-Induced Obesity.
Valle M; St-Pierre P; Pilon G; Marette A
Nutrients; 2020 Jul; 12(8):. PubMed ID: 32751772
[TBL] [Abstract][Full Text] [Related]
12. Chronic fructose intake accelerates non-alcoholic fatty liver disease in the presence of essential hypertension.
Lírio LM; Forechi L; Zanardo TC; Batista HM; Meira EF; Nogueira BV; Mill JG; Baldo MP
J Diabetes Complications; 2016; 30(1):85-92. PubMed ID: 26597602
[TBL] [Abstract][Full Text] [Related]
13. α-Amyrin attenuates high fructose diet-induced metabolic syndrome in rats.
Prabhakar P; Reeta KH; Maulik SK; Dinda AK; Gupta YK
Appl Physiol Nutr Metab; 2017 Jan; 42(1):23-32. PubMed ID: 27911087
[TBL] [Abstract][Full Text] [Related]
14. Sweetening yoghurt with glucose, but not with saccharin, promotes weight gain and increased fat pad mass in rats.
Boakes RA; Kendig MD; Martire SI; Rooney KB
Appetite; 2016 Oct; 105():114-28. PubMed ID: 27189382
[TBL] [Abstract][Full Text] [Related]
15. Combination of alcohol and fructose exacerbates metabolic imbalance in terms of hepatic damage, dyslipidemia, and insulin resistance in rats.
Alwahsh SM; Xu M; Schultze FC; Wilting J; Mihm S; Raddatz D; Ramadori G
PLoS One; 2014; 9(8):e104220. PubMed ID: 25101998
[TBL] [Abstract][Full Text] [Related]
16. Fructose containing sugars modulate mRNA of lipogenic genes ACC and FAS and protein levels of transcription factors ChREBP and SREBP1c with no effect on body weight or liver fat.
Janevski M; Ratnayake S; Siljanovski S; McGlynn MA; Cameron-Smith D; Lewandowski P
Food Funct; 2012 Feb; 3(2):141-9. PubMed ID: 22159273
[TBL] [Abstract][Full Text] [Related]
17. Combined high-fat diet and sustained high sucrose consumption promotes NAFLD in a murine model.
Torres-Villalobos G; Hamdan-Pérez N; Tovar AR; Ordaz-Nava G; Martínez-Benítez B; Torre-Villalvazo I; Morán-Ramos S; Díaz-Villaseñor A; Noriega LG; Hiriart M; Medina-Santillán R; Castillo-Hernandez Mdel C; Méndez-Sánchez N; Uribe M; Torres N
Ann Hepatol; 2015; 14(4):540-6. PubMed ID: 26019041
[TBL] [Abstract][Full Text] [Related]
18. Dual probiotic strains suppress high fructose-induced metabolic syndrome.
Park DY; Ahn YT; Huh CS; McGregor RA; Choi MS
World J Gastroenterol; 2013 Jan; 19(2):274-83. PubMed ID: 23345951
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologic inhibition of ketohexokinase prevents fructose-induced metabolic dysfunction.
Gutierrez JA; Liu W; Perez S; Xing G; Sonnenberg G; Kou K; Blatnik M; Allen R; Weng Y; Vera NB; Chidsey K; Bergman A; Somayaji V; Crowley C; Clasquin MF; Nigam A; Fulham MA; Erion DM; Ross TT; Esler WP; Magee TV; Pfefferkorn JA; Bence KK; Birnbaum MJ; Tesz GJ
Mol Metab; 2021 Jun; 48():101196. PubMed ID: 33667726
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol and fenofibrate ameliorate fructose-induced nonalcoholic steatohepatitis by modulation of genes expression.
Abd El-Haleim EA; Bahgat AK; Saleh S
World J Gastroenterol; 2016 Mar; 22(10):2931-48. PubMed ID: 26973390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
